Clin2
NCT07712718Possibly a fitRecruiting

A study of how a new drug leaves the body

Healthy Volunteers

This trial studies a new investigational drug called MRM-3379 in healthy men. It uses a tiny amount of a radioactive marker to track how the drug moves through the body, how it's broken down, and how it leaves. Participating helps researchers learn how to dose the drug safely in future studies.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
8 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are a man between 18 and 55 years old.
  • You have a body weight between 110 and 242 pounds, with a BMI between 18 and 32.
  • You are in generally good health (no major medical conditions).
  • You have not taken any vaccines in the last 30 days.
  • You have not used St. John's wort or other drugs that affect drug processing in the last 30 days.
  • You have not participated in more than 2 other radioactive drug studies in the past year, and at least 4 months have passed since your last one.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07788482Not yet recruiting· Phase 1
Mass balance study of a new drug in healthy adults

This study looks at how a new drug is processed by the body in healthy adults. It will help understand how the drug is absorbed, distributed, and eliminated.

Beijing, Beijing Municipality
NCT07744828Not yet recruiting· Phase 1
How a new drug moves through the body in healthy men

This study tests a new drug to see how it is absorbed, distributed, and removed from the body. It is given as a shot to healthy men, and the results will help determine the right dose for future studies.

Auckland
NCT07522970Recruiting· Phase 1
Safety and Tolerability Study of LG-0317 in Healthy Adults

This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.

Shanghai, Shanghai Municipality
NCT07311811Not yet recruiting· Phase 1
Study of two drugs in healthy volunteers

This trial tests how two experimental drugs, IN-M00007 and IN-R00007, move through the body and how safe they are. It is for healthy adults to gather basic information before testing in patients.

Seoul
NCT07516899Not yet recruiting· Phase 1
How Your Body Processes a New Experimental Drug

This study tests how a healthy male body absorbs, uses, and removes a new experimental medication. Researchers track the drug's path through your body using a special radioactive marker to understand how it works and ensure it's safe.

Wuxi, Jiangsu
NCT07708493Not yet recruiting· Phase 1
Study of a new medicine in healthy men with normal or overweight

This study tests how a new medicine (BI 3034701) moves through the body in healthy men who have normal weight or are overweight. It helps find the right dose and understand how the medicine works.

Hear when a new Healthy Volunteers trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.